Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase 3 4Phase 1 2

Status

Completed 5Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 5

Study Type

Interventional 6

Sponsor

Cancer Type

Dermatologic 4Lymphoid 2

Conditions

Keratosis, Actinic 4Pain 2Lymphoma, Follicular 2Acute Pain 2

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Diclofenac × Clear all
NCT02406014 2025-02-24

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

LEO Pharma

Phase 4 Completed
502 enrolled
Dermatologic

Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT00777127 2022-02-07

LEIDA

Viatris Inc.

Phase 4 Completed
258 enrolled
Dermatologic

Keratosis, Actinic

NCT01453179 2022-02-07

LEIDA 2

Viatris Inc.

Phase 4 Completed
221 enrolled
Dermatologic

Keratosis, Actinic

NCT01982539 2020-05-07

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Depomed

Phase 4 Completed
25 enrolled 8 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

NCT02287350 2017-07-11

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Depomed

Phase 4 Completed
51 enrolled 45 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡